Glioblastoma: current status, emerging targets, and recent advances

A Thakur, C Faujdar, R Sharma, S Sharma… - Journal of Medicinal …, 2022 - ACS Publications
Glioblastoma (GBM) is a highly malignant brain tumor characterized by a heterogeneous
population of genetically unstable and highly infiltrative cells that are resistant to …

[HTML][HTML] Harnessing mitochondrial metabolism and drug resistance in non-small cell lung cancer and beyond by blocking heat-shock proteins

B Parma, H Wurdak, P Ceppi - Drug Resistance Updates, 2022 - Elsevier
Lung cancer is the leading cause of cancer-related deaths worldwide, with non-small cell
lung cancer (NSCLC) being the predominant histological subtype. Despite the emergence of …

Roles and drug development of METTL3 (methyltransferase-like 3) in anti-tumor therapy

P Xu, R Ge - European journal of medicinal chemistry, 2022 - Elsevier
Methyltransferase complex, such as METTL3/METTL14/WTP, catalyze N 6-methyladenosine
(m 6 A), which is the most abundant mRNA modification in mammals. Besides acting as am …

Deciphering the lexicon of protein targets: a review on multifaceted drug discovery in the era of artificial intelligence

S Nandi, S Bhaduri, D Das, P Ghosh… - Molecular …, 2024 - ACS Publications
Understanding protein sequence and structure is essential for understanding protein–
protein interactions (PPIs), which are essential for many biological processes and diseases …

Androgen receptor, although not a specific marker for, is a novel target to suppress glioma stem cells as a therapeutic strategy for glioblastoma

N Zhao, F Wang, S Ahmed, K Liu, C Zhang… - Frontiers in …, 2021 - frontiersin.org
Targeting androgen receptor (AR) has been shown to be promising in treating glioblastoma
(GBM) in cell culture and flank implant models but the mechanisms remain unclear. AR …

Targeting heat shock proteins in Malignant brain tumors: from basic research to clinical trials

A Babi, K Menlibayeva, T Bex, A Doskaliev… - Cancers, 2022 - mdpi.com
Simple Summary Heat shock proteins (HSPs) play an important role in cellular metabolism
and therefore are highly expressed in malignant brain tumors. In the current review, the …

Targeting androgen receptor in glioblastoma

X Gan, X Wang, Y Liu - Critical Reviews in Oncology/Hematology, 2023 - Elsevier
Glioblastomas are primary brain tumors that originate from glial stem cells or progenitor
cells. There is a large difference in the incidence of glioblastoma between males and …

Astragalus membranaceus Extract Induces Apoptosis via Generation of Reactive Oxygen Species and Inhibition of Heat Shock Protein 27 and Androgen Receptor in …

SY Kim, JE Park, HJ Lee, DY Sim, CH Ahn… - International Journal of …, 2024 - mdpi.com
Although Astragalus membranaceus is known to have anti-inflammatory, anti-obesity, and
anti-oxidant properties, the underlying apoptotic mechanism of Astragalus membranaceus …

Lead Optimization of Androgen Receptor-HSP27 Disrupting Agents in Glioblastoma

Y Li, C Orahoske, F Salem, A Johnson… - Journal of medicinal …, 2023 - ACS Publications
Glioblastoma (GBM) is the most common malignant brain tumor with poor prognosis under
the current standard treatment. It is critical to develop new approaches to selectively battle …

Pharmacokinetic and brain distribution study of an anti‐glioblastoma agent in mice by HPLC–MS/MS

Y Li, R Dano, C Li, W Zhang, JD Lathia… - Biomedical …, 2022 - Wiley Online Library
Previously compound I showed great anti‐glioblastoma activity without toxicity in a mouse
xenograft study. In this study, a sensitive and rapid high‐performance liquid chromatography …